Free Trial

Vicarious Surgical Q2 2024 Earnings Report

Vicarious Surgical logo
$6.38 -0.19 (-2.82%)
As of 03:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vicarious Surgical EPS Results

Actual EPS
-$2.86
Consensus EPS
-$2.98
Beat/Miss
Beat by +$0.12
One Year Ago EPS
N/A

Vicarious Surgical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vicarious Surgical Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

Vicarious Surgical Earnings Headlines

Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.
See More Vicarious Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vicarious Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vicarious Surgical and other key companies, straight to your email.

About Vicarious Surgical

Vicarious Surgical (NYSE:RBOT). operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

View Vicarious Surgical Profile

More Earnings Resources from MarketBeat